Table 1 Demographic and clinical characteristics of annual health assessment participants.

From: Association of MPO levels with cardiometabolic disease stratified by atherosclerotic cardiovascular risk and intensity of therapy in a workforce population

Variables

High MPO

(≥ 540 pmol/L)

Low MPO

(< 470 pmol/L)

P value

n = 763

n = 19,180

Female, % (n)

68.7 (524)

63.6 (12,189)

< 0.001

Smoking, % (n)

11.0 (84)

10.0 (1,922)

0.4

Diabetes, % (n)

23.9 (182)

12.5(2,389)

< 0.001

Hypertension, % (n)

45.6 (348)

36.1 (6,916)

< 0.001

Age, years

50.0 ± 11.0

48.7 ± 11.1

0.002

Body mass index, kg/m

33.8 ± 8.6

29.1 ± 6.6

< 0.001

Blood pressure- diastolic, mm Hg

78.0 ± 10.7

77.3 ± 10.6

0.04

Blood pressure- systolic, mm Hg

125.1 ± 16.9

124.2 ± 16.2

0.3

LDL cholesterol, mg/dL

109.2 ± 31.7

111.6 ± 32.5

0.04

HDL cholesterol, mg/dL

52.0 ± 14.5

55.7 ± 15.0

< 0.001

HbA1c, %

6.1 ± 1.7

5.6 ± 0.9

< 0.001

Glucose, mg/dL

113.8 ± 53.4

99.5 ± 25.6

< 0.001

hs-CRP, mg/L

5.4 ± 3.6

2.9 ± 3.0

< 0.001

  1. Data are mean ± standard deviation unless otherwise indicated. Individuals with medium MPO results (n = 829) are not listed.
  2. Smoking: Current status (self-report or determined based on detection of cotinine in blood during health examination).
  3. Diabetes: Self-reported or determined during health examination (fasting blood glucose > 125 or A1C > 6.4).
  4. Hypertension: Self-reported or measured during health examination (systolic BP ≥ 140 or diastolic BP ≥ 90).
Back to article page